Aptevo Therapeutics (AP82.F) Q2 2026 Earnings

May 13Confirmed
Q4 2025
Q2 2026
-34.75
-24.76
-14.77
-4.78

Details

Expected EPS
-4.77904
Actual EPS
-5.470294
Surprise EPS
-0.69
Surprise Percent
-14.46%

Description

⁨Aptevo Therapeutics⁩ (⁦AP82.F⁩) has reported earnings of ⁦-5.470294⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts